Navigation Links
Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference
Date:7/9/2009

FRANKLIN, Mass., July 9 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced today that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the "Innovations in Diabetes" Conference on, Tuesday, July 14, 2009 at 5:30 pm ET. The presentation will occur live and will be held at The Pier V Hotel at the Inner Harbor in Baltimore.

"We are honored to have been selected to present at this prestigious conference which highlights cutting edge technologies in the field of diabetes management," stated Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics. "We look forward to introducing Symphony, our needle-free, continuous glucose monitoring technology, to the large audience of physician thought-leaders from around the world who will be attending the conference, and to providing an update on our notable progress toward our goal of making Symphony available to physicians and patients in early 2010."

About Echo Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude(TM) SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

About Innovara

Innovara, Inc. is a global strategic consulting, educational development, and business development corporation specializing in forming unique alliances between MDs and medical institutions involved in medical research and education, with the aim of aiding advancing medical education, disease management and patient care worldwide. Innovara was founded over 25 years ago and is dedicated to working with globally recognized medical institutions, physicians, health care and other professionals, bringing the "latest from the best" in medical education and advances in research to physicians and other healthcare professionals around the world. For more information contact: Margot DeFrance, Executive Vice President Business Development, margot.defrance@innovara.com.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the efficacy of Echo's Symphony tCGM System, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM System, the ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's ability to develop, market and sell diagnostic products based on its skin permeation platform technologies, including the Symphony tCGM System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM System. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K for the year ended December 31, 2008, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

    10 Forge Parkway
    Franklin, MA 02038, USA
    Tel: 1+ 877-476-6878
    Fax: 1+ 508-553-8760
    www.echotx.com


    For More Information:
    Patrick T. Mooney, MD
    Chairman and Chief Executive Officer
    (508)-530-0329


'/>"/>
SOURCE Echo Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway
2. New Report Just Published: World Multiple Myeloma Therapeutics Market Report
3. New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
4. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
5. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
6. Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo-Regeneration
7. Hyperion Therapeutics Raises $60 Million Series C
8. Cornerstone Therapeutics Joins the Russell 3000(R) Index
9. Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts
10. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
11. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... When MetLoop first ... it was something that contractors should have at their disposal on a daily ... Butch, CertainTeed’s Director of Contractor Programs. , As a result, Metloop and ...
(Date:5/31/2016)... Greifensee, Switzerland (PRWEB) , ... May 31, 2016 , ... ... adopt this model in their laboratories as well. However, laboratories have different challenges compared ... many benefits of lean operations in the lab, METTLER TOLEDO has developed the ...
(Date:5/31/2016)... ... ... Spectrum Aquatics has launched a brand new ADA pool lift, the Motion Trek ... in mind. , “Over the last two years our key customers and designers plus ... is a necessary requirement for certain facilities with specific needs,” said Nabil Khaled, Spectrum ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview on The Greenburgh Report ... Rochelle, NY-based WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross ... “modern medical money maelstrom.” , During the interview with Mr. Feiner that aired ...
(Date:5/31/2016)... N.J. (PRWEB) , ... May 31, 2016 , ... ... and print media enterprise focused on patients with cancer, has added Cancer ... readers and website visitors with more timely content on continuing successful careers while ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... According to a new market ... by Type (Human, Animal Pathology), by End User (Pharmaceutical ... - Global Forecasts to 2021", published by MarketsandMarkets, studies ... of 2016 to 2021. This market is expected to ... Million in 2016, at a CAGR of 12.1%. ...
(Date:5/31/2016)... May 31, 2016 Aloe vera ... food, cosmetics and pharmaceuticals, with global volume to surpass ... 1.6 Bn. Demand for aloe vera extracts ... yogurts will continue its upward momentum in 2016 as ... boost positive sentiment on aloe vera, with wide-ranging applications ...
(Date:5/31/2016)... , May 31, 2016 ... World Health Assembly zur Eliminierung von viraler Hepatitis ... Mitgliedsstaaten eine historische Verpflichtung eingegangen, virale Hepatitis bis ... . World Health Assembly haben sich die ... bzgl. viraler Hepatitis (Global Viral Hepatitis Strategy) zu ...
Breaking Medicine Technology: